Oumédaly Reman

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study

Sylvie Castaigné, Cécile Pautas, Christine Terré et al. · The Lancet · 2012 · 975 citations

Hematological Malignancy, Oncology, Gemtuzumab Ozogamicin +8

Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial

Xavier Thomas, Jean-Michel Boiron, Françoise Huguet et al. · Journal of Clinical Oncology · 2004 · 541 citations · Full text

Chemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin's Disease

Christophe Fermé, Houchingue Eghbali, J.H. Meerwaldt et al. · New England Journal of Medicine · 2007 · 444 citations · Full text

Omitting Radiotherapy in Early Positron Emission Tomography–Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 Trial

John Raemaekers, Marc André, Massimo Federico et al. · Journal of Clinical Oncology · 2014 · 381 citations · Full text

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome–positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study

Adrienne de Labarthe, Philippe Rousselot, Françoise Huguet‐Rigal et al. · Blood · 2006 · 343 citations · Full text